$13.43
+0.01 (+0.07%)
As of Jun 21, 10:03 PM ET ·
Analyst Consensus
Strong Sell
13
Analysts
Moderate
Coverage
Buy 0 0%
Hold 7 54%
Sell 6 46%
Price Target
Analyst Price Target +573.1% upside
Low Target $73.92
Average Target $90.40
High Target $125.40
Current Price $13.43
Current
$13.43
Target
$90.40
$73.92 $90.40 avg $125.40
Scenario Analysis
Bear Case
$73.92
450.4%
Low target
Base Case
$90.40
+573.1%
Avg target
Bull Case
$125.40
+833.7%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$13.49
-0.4% from high
52-Week Low
$5.69
+136.0% from low
50-Day SMA
$7.87
+70.6% vs SMA
200-Day SMA
$8.85
+51.8% vs SMA
RSI (14)
32.1
Neutral
Target vs 52W High
$90.40
+570.1% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 79% $1,330.33 +20.2%
RDY
Dr. Reddy's Laboratories
Sell 44 50% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +25.3%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +33.2%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +37.1%
BMY
Bristol-Myers Squibb Co
Hold 36 39% $174.50 +214.2%
ZTS
Zoetis Inc
Buy 24 58% $209.87 +173.1%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -34.5%